Friday, 4 April 2025
27.2 C
Singapore
28.1 C
Thailand
20.3 C
Indonesia
26.9 C
Philippines

Bioptimus secures US$41M to create groundbreaking AI for biology

French startup Bioptimus raises US$41M to develop AI that simulates biological processes, driving medical, biotech, and cosmetic innovations.

A French AI startup, Bioptimus, has raised US$41 million to develop an innovative foundational AI model explicitly designed for biology. This cutting-edge technology aims to simulate biological processes and drive medical, pharmaceutical, and even cosmetic discoveries.

A new era of biology

Just as OpenAIโ€™s ChatGPT revolutionised text-based interactions, Bioptimus plans to transform the understanding of biology by creating a model capable of simulating biological systems. The model will leverage raw data from molecules to entire organisms, enabling scientists to predict disease outcomes and develop more effective treatments.

Jean-Philippe Vert, co-founder and CEO of Bioptimus, describes the technology as โ€œthe GPT of biologyโ€ but with a focus on biological simulations instead of text generation. This approach could redefine how researchers analyse and interpret biological data, pushing the boundaries of science in unprecedented ways.

โ€œEssentially, itโ€™s like the GPT of biology โ€” but instead of generating text, weโ€™re simulating biology,โ€ Vert explained.

Franceโ€™s rise as an AI powerhouse

France is quickly becoming a hub for AI innovation. Over the past 18 months, several generative AI startups, including Mistral AI, Hugging Face, and H, have secured significant investments. Bioptimus, founded just last year, has already raised US$76 million in total funding, including a US$35 million seed round shortly after its launch.

Bioptimus benefits from the expertise of its six co-founders, such as Rodolphe Jenatton, who previously worked as a senior research scientist at Amazon and Google. Vert himself is the chief R&D officer at Owkin, another French AI-focused biotech unicorn. Owkin, a pioneer in using AI for drug discovery, has amassed a wealth of multimodal patient data, which Bioptimus is now utilising to train its foundational model.

Rather than embedding the foundational model development within Owkin, the team created Bioptimus as an independent entity. This approach allows for a focused effort on building large-scale foundational models while maintaining flexibility in securing resources like data and computing power.

Expanding horizons

Since its inception, Bioptimus has launched H-Optimus-0, an open-source foundation model for pathology, trained on millions of images to advance disease diagnosis and research, including cancer. With its latest funding, the company plans to enhance its AI platform using a broader range of data sources and develop partnerships with pharmaceutical and biotech companies.

A multi-modal foundation model, set to launch later this year, will span the entire biological spectrum and offer applications across various industries. Vert believes the model will pave the way for breakthroughs beyond healthcare, unlocking biological discoveries in unimaginable ways.

โ€œBeyond pharmaceuticals, this model will unlock limitless possibilities across many other industries, driving biological discoveries in ways we are only beginning to imagine,โ€ Vert noted.

The US$41 million funding round was led by Cathay Innovation, a U.S.-based company, with contributions from Sofinnova Partners, Bpifrance, Andera Partners, Hitachi Ventures, and others. This injection of capital solidifies Bioptimusโ€™s position as a frontrunner in developing AI tools for biology.

Hot this week

Google’s Gemini 2.5 Pro AI model is now available for all users

Google's Gemini 2.5 Pro AI model is now available for all users, offering advanced coding and reasoning abilities with a free trial for Gemini Advanced.

Informatica introduces new AI features to boost cloud data integration and management

Informatica adds AI tools to simplify data integration and improve enterprise access to AI-ready data across its cloud platform.

Anthropic introduces Claude for Education, a new AI chatbot plan for universities

Anthropic launches Claude for Education, an AI chatbot plan for universities that offers advanced learning tools and administration support.

Apple Intelligence now supports English (Singapore) with the latest update

Appleโ€™s latest update brings Apple Intelligence support for English (Singapore), making AI features more accessible without needing US English settings.

Apple may launch an AI-powered Health app with a coaching feature next year

Apple may introduce an AI-powered Health app with coaching, food tracking, and fitness guidance in 2026, possibly as a new subscription service.

Spotify introduces AI-powered ads and programmatic ad buying

Spotify unveils AI-powered ads and the Spotify Ad Exchange, making it easier for advertisers to reach Gen Z listeners with real-time bidding.

YouTube expands shopping affiliate programme in Singapore through Shopee partnership

YouTube teams up with Shopee to launch its Shopping affiliate programme in Singapore, giving creators new ways to monetise their content.

Misconceptions about STEM careers continue to deter young women in Singapore

New research shows stereotypes and lack of support are deterring young women from STEM careers, posing a risk to Singaporeโ€™s innovation goals.

Synagie and HKT launch ShopHK to help Hong Kong brands expand into Southeast Asia

Synagie and HKT launch ShopHK, helping Hong Kong SMEs tap into Southeast Asia's booming US$600 billion e-commerce market.

Related Articles